Table 1. Baseline characteristics of the subjects.
| GCL2505 | Placebo | |
|---|---|---|
| Subjects (N) | 69 | 68 |
| Male | 46 | 41 |
| Female | 23 | 27 |
| Age (years) | 46.9 ± 8.8 | 46.9 ± 8.7 |
| Height (cm) | 167.0 ± 8.5 | 166.6 ± 8.0 |
| Weight (kg) | 75.0 ± 8.4 | 74.9 ± 8.6 |
| BMI (kg/m2) | 26.8 ± 1.5 | 26.9 ± 1.5 |
| Waist circumference (cm) | 93.0 ± 4.8 | 92.9 ± 3.8 |
| Hip circumference (cm) | 98.4 ± 3.4 | 98.3 ± 3.2 |
| WHR | 0.95 ± 0.04 | 0.94 ± 0.03 |
| Visceral fat area (cm2) | 133.4 ± 29.6 | 124.3 ± 26.4 |
| Subcutaneous fat area (cm2) | 215.9 ± 55.8 | 219.9 ± 43.7 |
| Total fat area (cm2) | 349.3 ± 60.5 | 344.2 ± 45.9 |
Values are means ± SD. BMI: Body Mass Index; WHR: waist to hip ratio.
p-values were analyzed by unpaired t-test.